Japan Artificial Organs & Bionic Implants Market - Growth, Trends & Forecast (2020 - 2025)

The market is segmented by Type (Artificial Organ, Bionics).

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

CAGR:

7.5 %

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

Artificial organs and bionics are mechanical devices that can be implanted into humans to substitute for a natural organ or offer support towards restoring of certain bodily functions by which the patient may be able to return to normal life. Japan has one of the strictest organ donation laws in the world. As result there is a scarcity of organ donors in Japan, leading to unattended patients. Growing geriatric population is another concern for Japan. Older population are prone to organ failures. This problem coupled with scarcity of organs has increased the demand for organ donations. As a result, the artificial organ market is gaining prevalence in Japan. Rate of road mishaps and resulting disabilities is also increasing in Japan. This has increased the demand for bionics market in Japan as well.

However, high cost of devices and procedures and risk of compatibility issues and malfunctions has been restraining the market growth.

Scope of the report

As per the scope of the report, Artificial organs and bionics are mechanical devices that can be implanted into humans to substitute for a natural organ or offer support towards restoring of certain bodily functions by which the patient may be able to return to normal life

In the report, a detailed analysis of the artificial organs and bionic implants market in Japan is provided. The market is evaluated by collating revenues generated across segments, categorized by Type.

By Type
Artificial Organ
Artificial Heart
Artificial Kidney
Artificial Lungs
Cochlear Implants
Other Organ Types
Bionics
Vision Bionics
Cardiac Bionics
Orthopedic Bionic
Other Bionics

Report scope can be customized per your requirements. Click here.

Key Market Trends

Artificial Heart Transplant is expected to Dominate the Market

As per 2017 United Nations on “World Aging Population”, in 2017, Japan has the highest percentage of population aged above 60 years of age, with 33.4% of the population belonging to this demographic. Moreover, the report estimates that this demographic will increase to 42.4% by 2050.

The elderly population is susceptible to suffer from various chronic ailments including kidney diseases, cardiovascular disorders, and neurological conditions, among the others. With the growing age, the probability of suffering from organ failures escalates significantly. As a result, increasing geriatric population in Japan is expected to expand artificial organs and bionics market in the future.

To understand key trends, Download Sample Report

Competitive Landscape

Japan is a developed country and has trade relations other developed nations. As a result, it enjoys the presence of most of the global players in the Japan artificial organs and bionic implants market. Moreover, international players like Asahi Kasei Corporation are Japanese multinationals. This, along with the presence of other global players, has made the Japanese market very competitive for artificial organs and bionic implants.

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increased Incidence of Disabilities and Organ Failures

      2. 4.2.2 Rising Geriatric Population in Japan

      3. 4.2.3 High Incidence of Road Accidents Leading to Amputations

      4. 4.2.4 Scarcity of Donor Organs

    3. 4.3 Market Restraints

      1. 4.3.1 Expensive Procedures

      2. 4.3.2 Risk of Compatibility Issues and Malfunctions

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 Artificial Organ

        1. 5.1.1.1 Artificial Heart

        2. 5.1.1.2 Artificial Kidney

        3. 5.1.1.3 Artificial Lungs

        4. 5.1.1.4 Cochlear Implants

        5. 5.1.1.5 Other Organ Types

      2. 5.1.2 Bionics

        1. 5.1.2.1 Vision Bionics

        2. 5.1.2.2 Cardiac Bionics

        3. 5.1.2.3 Orthopedic Bionic

        4. 5.1.2.4 Other Bionics

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abiomed Inc

      2. 6.1.2 Asahi Kasei Medical Co Ltd

      3. 6.1.3 Baxter International, Inc.

      4. 6.1.4 Berlin Heart GmbH

      5. 6.1.5 Boston Scientific Corporation

      6. 6.1.6 Cochlear Limited

      7. 6.1.7 Cyberonics Inc.

      8. 6.1.8 Getinge AB

      9. 6.1.9 Medtronic Inc

      10. 6.1.10 Ossur hf

  7. *List Not Exhaustive
  8. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

Related Reports